279 related articles for article (PubMed ID: 18753636)
41. I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development.
Orinska Z; Föger N; Huber M; Marschall J; Mirghomizadeh F; Du X; Scheller M; Rosenstiel P; Goldmann T; Bollinger A; Beutler BA; Bulfone-Paus S
Blood; 2010 Oct; 116(15):2665-75. PubMed ID: 20595514
[TBL] [Abstract][Full Text] [Related]
42. c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells.
Wisniewski D; Strife A; Clarkson B
Leukemia; 1996 Sep; 10(9):1436-42. PubMed ID: 8751459
[TBL] [Abstract][Full Text] [Related]
43. Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.
Louria-Hayon I; Frelin C; Ruston J; Gish G; Jin J; Kofler MM; Lambert JP; Adissu HA; Milyavsky M; Herrington R; Minden MD; Dick JE; Gingras AC; Iscove NN; Pawson T
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20599-604. PubMed ID: 24297922
[TBL] [Abstract][Full Text] [Related]
44. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
[TBL] [Abstract][Full Text] [Related]
45. Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling.
Ho CCM; Chhabra A; Starkl P; Schnorr PJ; Wilmes S; Moraga I; Kwon HS; Gaudenzio N; Sibilano R; Wehrman TS; Gakovic M; Sockolosky JT; Tiffany MR; Ring AM; Piehler J; Weissman IL; Galli SJ; Shizuru JA; Garcia KC
Cell; 2017 Mar; 168(6):1041-1052.e18. PubMed ID: 28283060
[TBL] [Abstract][Full Text] [Related]
46. RIN3 is a negative regulator of mast cell responses to SCF.
Janson C; Kasahara N; Prendergast GC; Colicelli J
PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
[TBL] [Abstract][Full Text] [Related]
47. Differential use of BTK and PLC in FcεRI- and KIT-mediated mast cell activation: A marginal role of BTK upon KIT activation.
Simonowski A; Wilhelm T; Habib P; Zorn CN; Huber M
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118622. PubMed ID: 31837347
[TBL] [Abstract][Full Text] [Related]
48. Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cells.
Bondzi C; Litz J; Dent P; Krystal GW
Cell Growth Differ; 2000 Jun; 11(6):305-14. PubMed ID: 10910097
[TBL] [Abstract][Full Text] [Related]
49. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.
Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T
Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931
[TBL] [Abstract][Full Text] [Related]
50. Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells.
Shivakrupa R; Linnekin D
Cell Signal; 2005 Jan; 17(1):103-9. PubMed ID: 15451030
[TBL] [Abstract][Full Text] [Related]
51. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.
Gery S; Cao Q; Gueller S; Xing H; Tefferi A; Koeffler HP
J Leukoc Biol; 2009 Jun; 85(6):957-65. PubMed ID: 19293402
[TBL] [Abstract][Full Text] [Related]
52. The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways.
Fitau J; Boulday G; Coulon F; Quillard T; Charreau B
J Biol Chem; 2006 Jul; 281(29):20148-59. PubMed ID: 16644735
[TBL] [Abstract][Full Text] [Related]
53. Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation.
Li Y; He X; Schembri-King J; Jakes S; Hayashi J
J Immunol; 2000 May; 164(10):5199-206. PubMed ID: 10799879
[TBL] [Abstract][Full Text] [Related]
54. Lipid rafts are required for Kit survival and proliferation signals.
Jahn T; Leifheit E; Gooch S; Sindhu S; Weinberg K
Blood; 2007 Sep; 110(6):1739-47. PubMed ID: 17554062
[TBL] [Abstract][Full Text] [Related]
55. Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein (MAP) kinase activation in hematopoietic cells.
Nonami A; Kato R; Taniguchi K; Yoshiga D; Taketomi T; Fukuyama S; Harada M; Sasaki A; Yoshimura A
J Biol Chem; 2004 Dec; 279(50):52543-51. PubMed ID: 15465815
[TBL] [Abstract][Full Text] [Related]
56. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells.
Linnekin D; DeBerry CS; Mou S
J Biol Chem; 1997 Oct; 272(43):27450-5. PubMed ID: 9341198
[TBL] [Abstract][Full Text] [Related]
57. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
[TBL] [Abstract][Full Text] [Related]
58. Early signaling pathways activated by c-Kit in hematopoietic cells.
Linnekin D
Int J Biochem Cell Biol; 1999 Oct; 31(10):1053-74. PubMed ID: 10582339
[TBL] [Abstract][Full Text] [Related]
59. Balanced interactions between Lyn, the p85alpha regulatory subunit of class I(A) phosphatidylinositol-3-kinase, and SHIP are essential for mast cell growth and maturation.
Ma P; Vemula S; Munugalavadla V; Chen J; Sims E; Borneo J; Kondo T; Ramdas B; Mali RS; Li S; Hashino E; Takemoto C; Kapur R
Mol Cell Biol; 2011 Oct; 31(19):4052-62. PubMed ID: 21791602
[TBL] [Abstract][Full Text] [Related]
60. Requirement of Gab2 for mast cell development and KitL/c-Kit signaling.
Nishida K; Wang L; Morii E; Park SJ; Narimatsu M; Itoh S; Yamasaki S; Fujishima M; Ishihara K; Hibi M; Kitamura Y; Hirano T
Blood; 2002 Mar; 99(5):1866-9. PubMed ID: 11861309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
